Tuesday - August 4, 2026
WilmerHale Advises Underwriters on Q32 Bio's $200 Million Public Offering
July 17, 2026
WASHINGTON, July 17 [Category: BizLaw/Legal] -- WilmerHale, a law firm, posted the following news:

* * *

WilmerHale Advises Underwriters on Q32 Bio's $200 Million Public Offering

*

WilmerHale advised the underwriters in Q32 Bio Inc.'s public offering of 6,027,399 shares of common stock and pre-funded warrants to purchase 4,931,506 shares of common stock. Q32 Bio, a clinical stage biotechnology company focused on developing innovative . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products